COR Q4 2018 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q4 2018 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$43.3B+10.7% YoY

Gross Profit

$912M2.1% margin

Operating Income

$254M0.6% margin

Net Income

$233M0.5% margin

EPS (Diluted)

$1.07

QoQ Revenue Growth

+0.4%

Cash Flow

Operating Cash Flow

$665M

Free Cash Flow

$577M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$37.7B

Total Liabilities

$35.0B

Stockholders' Equity

$2.9B

Cash & Equivalents

$2.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43.3B	$39.1B	+10.7%
Gross Profit	$912M	$1.1B	-14.6%
Operating Income	$254M	$507M	-49.8%
Net Income	$233M	-$295M	+179.2%

Revenue Segments

Pharmaceutical Distribution

$41.7B96%

Other Segments

$1.6B4%

Geographic Segments

Other Segments

$1.6B100%